Clinical Trials
93 trialsMMRC Horizon One: RRMM (MMRC-099)
Multiple Myeloma Research Consortium
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Eastern Cooperative Oncology Group
Testing the Investigational Agent Combination of Daratumumab, Bortezomib, and Dexamethasone Compared to the Usual Treatment of Cyclophosphamide, Bortezomib, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients With Kidney Failure
Eastern Cooperative Oncology Group
Fixed Duration vs Continuous Anti-CD38 Antibody Therapy Among Transplant Ineligible Older Adults With Newly-Diagnosed Multiple Myeloma
Canadian Cancer Trials Group
EMN19
European Myeloma Network B.V.
Study for Frail Patients With Newly Diagnosed Multiple Myeloma Treated With Daratumumab With Teclistamab or Talquetamab.
European Myeloma Network B.V.
CPD-DARA
Cancer Trials Ireland
RHUMM
Intergroupe Francophone du Myelome
TEC-CARE
Intergroupe Francophone du Myelome
ElLen
Intergroupe Francophone du Myelome
CAPTUR
Canadian Cancer Trials Group
MajesTEC-4
European Myeloma Network B.V.
A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant
European Myeloma Network B.V.
CARTITUDE-6
European Myeloma Network B.V.
Perseus
European Myeloma Network B.V.
EMN14
European Myeloma Network B.V.
A Study of Combination of Selinexor, Pomalidomide, and Dexamethasone (SPd) Versus Elotuzumab, Pomalidomide, and Dexamethasone (EloPd) in Subject With Previously Treated Multiple Myeloma
European Myeloma Network B.V.
EMN36
European Myeloma Network B.V.
DRAMMATIC
SWOG Cancer Research Network
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Eastern Cooperative Oncology Group
Daratumumab-bortezomib-dexamethasone (Dara-VCd) vs Bortezomib-Thalidomide-Dexamethasone (VTd), Then Maintenance With Ixazomib (IXA) or IXA-Dara
European Myeloma Network B.V.
Isa-RVD
Cancer Trials Ireland
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
SWOG Cancer Research Network
Cassiopeia
Intergroupe Francophone du Myelome
IsKia
European Myeloma Network B.V.
Iberdomide (Cc220) Maintenance After Asct in Newly Diagnosed MM Patients
European Myeloma Network B.V.
IFM2014-01
Intergroupe Francophone du Myelome
MyDRUG
Multiple Myeloma Research Consortium
Immuno-Oncology Drugs Elotuzumab, Anti-LAG-3 and Anti-TIGIT
Multiple Myeloma Research Consortium
BE-Dasatinib
Centro de Atencion e Investigacion Medica
S1304, Carfilzomib and Dexamethasone for Treating Patients With Relapsed or Refractory Myeloma
SWOG Cancer Research Network
wCCyd
European Myeloma Network B.V.
MIDAS
Intergroupe Francophone du Myelome
TAURUS
European Myeloma Network B.V.
EMN-COVID
European Myeloma Network B.V.
Carfilzomib In Combination With Bendamustine And Dexamethasone In Refractory Or Relapsed Multiple Myeloma
European Myeloma Network B.V.
Subcutaneous Velcade Plus Oral Melphalan and Prednisone or Plus Cycloposphamide and Prednisone or Plus Prednisone
European Myeloma Network B.V.
Maintenance Therapy With Subcutaneous Bortezomib
European Myeloma Network B.V.
Covimmunomm
Intergroupe Francophone du Myelome
Thalidomide and Prednisone After Autologous Stem Cell Transplantation Multiple Myeloma
Canadian Cancer Trials Group
Stem Cell Translpantation in Multiple Myeloma
European Society for Blood and Marrow Transplantation
CCD
European Myeloma Network B.V.
Assessment of Allogeneic Hematopoietic Cell Transplantation in Medicare Beneficiaries With Multiple Myeloma
Center for International Blood and Marrow Transplant Research
High-Dose Weekly Carfilzomib Plus Cyclophosphamide and Dexamethasone in the Treatment of Relapsed Multiple Myeloma
Canadian Cancer Trials Group
Lenalidomide and Melphalan in Treating Patients With Previously Untreated Multiple Myeloma
Canadian Cancer Trials Group
A Study of AT9283 in Patients With Relapsed or Refractory Multiple Myeloma
Canadian Cancer Trials Group
CPD
European Myeloma Network B.V.
CCD
European Myeloma Network B.V.
High-Dose Melphalan Plus Peripheral Stem Cell Transplantation in Treating Patients With Primary Systemic Amyloidosis
Eastern Cooperative Oncology Group
Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
Eastern Cooperative Oncology Group